Stocks and Investing Stocks and Investing
Thu, August 15, 2024
Wed, August 14, 2024

Ed Arce Upgraded (CDTX) to Strong Buy and Held Target at $24 on, Aug 14th, 2024


Published on 2024-10-28 13:39:53 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Upgraded "Cidara Therapeutics, Inc." (CDTX) to Strong Buy and Held Target at $24 on, Aug 14th, 2024.

Ed has made no other calls on CDTX in the last 4 months.



There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Stephen Brozak of "WBB Securities" Maintained at Strong Buy and Held Target at $40 on, Thursday, April 25th, 2024
Contributing Sources